Please use this identifier to cite or link to this item:
|Title:||AURANOFIN INHIBITS VIRULENCE IN PSEUDOMONAS AERUGINOSA||Authors:||TAN ZHEN WEI LEON||Keywords:||pseudomonas aeruginosa, virulence, drug discover, anti-virulence, microbiology||Issue Date:||8-Mar-2018||Citation:||TAN ZHEN WEI LEON (2018-03-08). AURANOFIN INHIBITS VIRULENCE IN PSEUDOMONAS AERUGINOSA. ScholarBank@NUS Repository.||Abstract:||Pseudomonas aeruginosa is widely attributed as the leading cause of hospital-acquired infections. Our work reveals a novel chemical compound which was found to attenuate virulence and biofilm maturation in P. aeruginosa. In this project, we initially screened for a P. aeruginosa QS inhibitors using high-throughput screening and yielded auranofin, which displayed sub-micro molar activity against LasR-mediated expression of lasB. Additionally, key virulence metabolites involving all levels of QS were also decreased on exposure to auranofin. Surprisingly, iTRAQ analysis of the P. aeruginosa proteome revealed that type III secretion system, type IV pili and biofilm maturation, in addition to inhibiting QS, were attenuated. Flow cell biofilm assays and showed that auranofin inhibits Vfr in vitro. Interestingly, auranofin also displays synergistic effects when used in combination with colistin. With a collaborator, we subsequently investigated the structure-activity relationship of auranofin by examining various analogues of auranofin for inhibition of LasB-Gfp expression as well as toxicity against several types of mammalian cells. We discovered two analogues, which were both more potent QS inhibitors, as well as less toxic to mammalian cells tested, as compared to auranofin.||URI:||http://scholarbank.nus.edu.sg/handle/10635/148344|
|Appears in Collections:||Ph.D Theses (Open)|
Show full item record
Files in This Item:
|TanZWL.pdf||21.56 MB||Adobe PDF|
checked on Oct 16, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.